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A B S T R A C T
Objectives: We analysed the concordance of rectal swab isolates and blood culture for Gram-negative
bacteria (GNB) isolates in neonates with a suspicion of neonatal sepsis admitted to a neonatal care unit in
Haiti.
Methods: We matched pairs of blood and rectal samples taken on the date of suspected sepsis onset in the
same neonate. We calculated the proportion of rectal isolates in concordance with the blood isolates by
species and genus. We calculated the negative predictive value (NPV) for GNB and extended-spectrum β-
lactamase (ESBL)-producing GNB for all rectal and blood isolate pairs in neonates with suspected sepsis.
Results: We identified 238 blood and rectal samples pairs, with 238 blood isolate results and 309 rectal
isolate results. The overall concordance in genus and species between blood and rectal isolates was 22.3%
[95% confidence interval (CI) 17.4–28.0%] and 20.6% (95% CI 16.0–26.2%), respectively. The highest
concordance between blood and rectal isolates was observed for samples with no bacterial growth (65%),
followed byKlebsiella pneumoniae (18%) and Klebsiella oxytoca (12%). The NPV of detecting GNB bacterial
isolates in rectal samples compared with those in blood samples was 81.6% and the NPV for ESBL-positive
GNB was 92.6%.
Conclusions: The NPV of rectal swab GNB isolates was high in all patient groups and was even higher for
ESBL-positive GNB. Clinicians can use the results from rectal swabs when taken simultaneously with
blood samples during outbreaks to inform the (de-)escalation of antibiotic therapy in those neonates that
have an ongoing sepsis profile.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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Neonatal sepsis is one of the main causes of neonatal morbidity
and mortality. It is estimated that approximately 3 million cases of
neonatal sepsis occur globally per year, of which 11–19% result in* Corresponding author at: Plantage Middenlaan 14, 1018 DD, Amsterdam, The
Netherlands.
E-mail address: annick.lenglet@amsterdam.msf.org (A. Lenglet).
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2213-7165/© 2020 The Authors. Published by Elsevier Ltd on behalf of International Societ
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).death [1]. Early detection and prompt empirical treatment of
suspected neonatal sepsis with broad-spectrum antibiotics is
common practice to avoid rapid progression to severe sepsis or
septic shock [2]. The highest proportion of the burden of neonatal
sepsis is carried by low- and middle-income countries [3]. The
diagnosis of neonatal sepsis is based on clinical suspicion, since
clinical signs and symptoms of neonatal sepsis are non-specific [4].
Worryingly, a recent study showed that nearly one-half of the
bacteria responsible for neonatal infections are resistant to first-
line (ampicillin or penicillin, and gentamicin) and second-liney for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-
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the World Health Organization (WHO) [5,6]. Also, resistance to
ampicillin and gentamicin has been reported to be as high as 71% in
Klebsiella spp. and 50% in Escherichia coli in neonates [3]. Outbreaks
of multidrug-resistant (MDR) bacteria are therefore increasingly
reported from neonatal intensive care units (NICUs) in such
settings [7,8].
Blood culture testing is considered the gold standard for the
confirmation of bacteraemia in patients with sepsis. Blood cultures
should be taken before antibiotics are administered in infants and
young children [4] and can be used to tailor antibiotic treatment to
neonates with suspected sepsis [9]. However, the positivity rate of
blood cultures in the neonatal patient population is low and can be
influenced by factors such as intrapartum antimicrobial adminis-
tration, antibiotics administered before blood culture draw, low
quantities of blood volume obtained from neonates for culture [10]
or absence of bacteraemia. Two systematic reviews from Africa and
Southeast Asia concluded that blood culture positivity in children
was low, ranging from 8.2% [95% confidence interval (CI) 7.9–8.4%]
to 6.6% (95% CI 6.3–6.9%) [11,12]. One recent study from South
Africa showed a blood culture positivity rate in children below the
age of 1 year with clinical signs and/or risk factors for severe
bacterial infection of 15.7% (95% CI 15.2–16.2%) (of which 44.3%
were due to pathogenic bacteria) [13].Fig. 1. Flow chart The gastrointestinal tract of hospitalised infants has been
shown to serve as a reservoir of bloodstream infections (BSIs)
caused by Candida spp., Klebsiella spp., E. coli and Pseudomonas spp.
[14]. Also, 20% of episodes of late-onset sepsis (LOS) in neonates are
caused by infections with Gram-negative bacteria (GNB) [14]. It
has also been shown that intestinal overgrowth is a predisposing
factor for sepsis development in the neonatal population [15,16].
Das et al. showed that there is an association between intestinal
colonisation and sepsis [16]. Neonates with intestinal colonisation
of GNB had a higher incidence of clinical sepsis than those without
GNB colonisation [16]. A meta-analysis by Folgori et al. in 2018
showed an association between GNB colonisation and a confirmed
BSI with GNB in neonates, but it did not conclude that routine
rectal screening in NICUs was recommended owing to limited
evidence [17]. The lack of evidence around the added value of rectal
screening for GNB colonisation in neonates admitted to NICUs was
also confirmed in another meta-analysis from 2017 [18].
Between 2011 and 2018, Médecins Sans Frontières (MSF)
managed the ‘Centre de Référence pour les Urgences Obstétricales’
(CRUO) in Port-au-Prince, Haiti, an emergency obstetric hospital
and associated neonatal care unit (NCU). In July 2014, the hospital
identified an increase in sepsis cases, and healthcare-associated
transmission of extended-spectrum β-lactamase (ESBL)-producing
Klebsiella pneumoniae was suspected [8]. In subsequent years,of study data.
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data). As a response to this outbreak, CRUO started routine blood
cultures on neonates who presented with suspected clinical sepsis.
As an enhanced surveillance measure and to strengthen infection
prevention and control measures, we also took simultaneous rectal
swabs from all neonates with suspected sepsis to better under-
stand colonisation with MDR-GNB. This strategy of enhanced
surveillance allowed us to isolate all neonates identified with
MDR-GNB [8].
There is limited evidence around the potential value of
identification of bacterial rectal colonisation in neonates in guiding
empirical treatment for neonatal sepsis. Data from the MDR-GNB
surveillance in CRUO therefore presented us with a unique
opportunity to further explore the relationship between colonisa-
tion, BSI and suspected clinical sepsis in this vulnerable patient
group in a low-resource context. We aimed to analyse the
concordance of rectal swab isolates and blood culture GNB isolates
in neonates with suspicion of neonatal sepsis in Haiti.
2. Materials and methods
2.1. Study setting
CRUO was a container hospital that opened in 2011 to improve
access to healthcare for women with complicated pregnancies and
their offspring in Port-au-Prince. The hospital contained 162 beds,
of which 56 beds were part of the NCU. The hospital closed in July
2018. Due to the clinical profile of women delivering in CRUO (e.g.
high prevalence of pre-eclampsia and eclampsia) and their
neonates (e.g. premature, low birthweight), a large proportion
of neonates admitted in CRUO received prophylactic antibiotic
treatment (with first-line treatment) immediately after birth.
2.2. Study population
We included data for all neonates diagnosed with suspected
neonatal sepsis after admission to CRUO between October 2014
and July 2018 and for whom simultaneous (within 24 h of each
other) blood and rectal samples were taken for culture on the date
of onset of their suspected sepsis. A clinical suspicion of neonatal
sepsis was defined as a neonate in the NCU who presented with
one or more of the following clinical signs: prolonged capillary
refill; certain skin changes (redness, sclerema); distended abdo-
men with/without haemorrhagic, brownish or bilious gastric
aspirates; tachypnoea; tachycardia; persistent jaundice; unstable
temperature; signs of disseminated intravascular coagulation
(bleeding from catheter sites, bloody secretions from nose and
mouth, petechiae); reduced muscle tone; and lethargy, apathy or
irritability. Early-onset sepsis (EOS) was defined as clinical sepsis
with a date of onset within 48 h after birth. Late-onset sepsis (LOS)
was defined as the onset of clinical sepsis after 48 h of life.
All clinical and epidemiological data were collected in the
routine Health Information System for MSF.
2.3. Microbiological diagnostics
After sample collection, blood samples were stored in an
incubator at 37 C and rectal samples were stored in a refrigerator
until the time of their transport to the laboratory. Samples were
sent on the day of collection to the Clinical Bacteriology Laboratory
of the Haitian Study Group on Kaposi’s Sarcoma and Opportunistic
Infections (GHESKIO) and were plated on MacConkey, Columbia
CNA agar and chocolate agar with Polyvitex plates and incubated
for 24 h at 37 C. Isolates were identified using the VITEK12
g-negative card, and antimicrobial susceptibility testing was
performed using the VITEK12 AST-N233 card. Presence of ESBLswas established through the double-disk synergy test (Comité de
l’Antibiogramme de la Société Française Microbiologie (CA-SFM)
2013 recommendations [19]) using Mueller–Hinton agar with
antibiotic-impregnated disks (3 cm distance between disks) for β-
lactamase detection or confirmation. Amoxicillin/clavulanic acid
was placed in the middle of the agar, surrounded by disks for third-
and fourth-generation cephalosporins (ceftazidime, cefotaxime,
ceftriaxone and cefepime) [8].
All microbiological data were collected in a specified Excel-
based database.
2.4. Data management
We merged the data from the Health Information System (n =
1141 neonates) with the microbiological database (n = 1377
samples) for the data analysis (Fig. 1). Prior to merging the
databases, we removed any observations from the two databases
that were for neonates who had been re-admitted for treatment or
microbiological results that were likely to be contaminants [20]. In
line with local protocols, we made the following assumptions: (i)
rectal and blood samples taken on the day of onset of their
suspected sepsis were taken at the same time; (ii) rectal and blood
samples were taken at the time that sepsis was diagnosed; and (iii)
rectal and blood samples were taken before administration of
antibiotic treatment. We removed all observations in the merged
data set that could not be matched (i.e. single blood or rectal
sample, or samples from the same patient that were not taken in
the same moment), that were not from blood or rectal swabs (i.e.
pus, etc.) and for patients for whom multiple blood samples were
taken on the same day (potentially due to a data quality issue). We
focused the analysis on GNB and therefore excluded all microbio-
logical results for Gram-positive bacterial isolates. In total, 238
matched samples from 238 patients were included for analysis,
with 238 bacterial isolate results from blood samples and 309
isolate results from rectal swabs.
2.5. Data analysis
We described the patient profile for which we had bacterial
isolate information available. For each individual patient (for
whom matched blood and rectal samples were available), we
calculated the time between the date of onset of sepsis and the
date of treatment with first-line antibiotic therapy (ampicillin and
gentamicin), second-line therapy (amikacin and ceftazidime) and
third-line therapy (meropenem). Thus, we could distinguish which
antibiotic therapy patients were receiving after their sepsis was
diagnosed. We compared the difference in isolate results between
neonates who received the different lines of antibiotic therapy to
explore whether second- or third-line treatment was associated
with higher rates of colonisation or blood culture positivity with
MDR bacteria.
We calculated the proportion and 95% CI of rectal isolates in
concordance with the blood isolates for each species and genus. CIs
were calculated using Wilson’s method [21]. We calculated the
sensitivity, specificity, positive predictive value (PPV) and negative
predictive value (NPV) for GNB and ESBL-producing GNB for all
rectal and blood isolate pairs in all suspected neonates with sepsis.
For example, for the NPV, we calculated the proportion of true
negatives (rectal isolate and blood isolate were not GNB) amongst
all non-GNB isolates in the rectal samples. We also explored these
four parameters in neonates who were diagnosed with EOS and
LOS, and compared neonates who had only received first-line
antibiotics and only second-line antibiotics at the time of sepsis
diagnosis. Concordance was reached when the species or the genus
identified in a blood isolate was the same in a rectal isolate. If there
were multiple rectal isolates per patient, concordance occurred if
Table 1
Bacterial isolates in blood and rectal samples.
Species Overall ESBL-producinga
Blood Rectal Blood Rectal
n % n % n % n %
No growth 194 81.5 40 12.9
Klebsiella oxytoca 20 8.4 44 14.2 19 95.0 30 68.2
Klebsiella pneumoniae 17 7.1 79 25.6 14 82.4 45 57.0
Enterobacter cloacae 3 1.3 23 7.4 11 47.8
Aeromonas hydrophila 1 0.4 4 1.3
Escherichia coli 1 0.4 48 15.5 12 25.0
Enterobacter aerogenes 1 0.4 5 1.6 1 100 2 40.0
Stenotrophomonas maltophilia 1 0.4 2 0.6
Citrobacter freundii 18 5.8 10 55.6
Pseudomonas aeruginosa 11 3.6
Klebsiella spp. 8 2.6 4 50.0
Acinetobacter baumannii 7 2.3
Acinetobacter junii 1 0.3
Acinetobacter lwoffii 1 0.3
Pantoea spp. 6 1.9
Proteus mirabilis 3 1.0
Citrobacter farmeri 2 0.6 1 50.0
Citrobacter koseri 1 0.3
Pseudomonas fluorescens 1 0.3
Pseudomonas mendocina 1 0.3
Pseudomonas stutzeri 1 0.3
Raoultella ornithinolytica 1 0.3 1 100
Serratia odorifera 1 0.3 1 100
Others 1 0.3 1 100
Total 238 309 34 118
ESBL, extended-spectrum β-lactamase.
a Percentage of total number of isolates of that species.
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McNemar’s test to compare the concordance between results of
the rectal and blood isolates for each patient.
All data cleaning and data analysis was conducted using Stata
Statistical Software: Release 15 (StataCorp LLC, College Station, TX,
USA).
3. Results
3.1. Overall results
We were able to match clinical and microbiological data from
854 patients with a total of 1358 samples (blood and rectal) who
were admitted to CRUO between January 2015 and June 2018 and
who displayed symptoms of suspected sepsis during their
admission period (Fig. 1). Following cleaning procedures, we
included data from 238 neonates in the final analysis (Fig. 1). Most
neonates were male (n = 126; 52.9%), their mean  standard
deviation (S.D.) birthweight was 1704.8  654.1 g [median 1525 g,
interquartile range (IQR) 1225–2027 g] and the mean  S.D.
gestational age was 33.4  4.0 weeks (median 33 weeks, IQR 30–36
weeks). Of the 238 neonates, 36 (15.1%) had EOS. We had
information on the type of antibiotic treatment received for 181
neonates (76.1%). The majority of neonates had received both first-
and second-line treatment (132/181; 72.9%) at the time of their
suspected sepsis onset.
A total of 238 pairs of blood and rectal swabs from neonates
with suspected sepsis were retained for this analysis for a total of
547 isolate results (blood = 238, rectal = 309). For 171 matched
blood and rectal sample pairs, no isolate or a single isolate was
identified in either sample. For 67 blood and rectal pairs, multiple
colonies of differing species were identified in the rectal swabs.
Amongst the blood and rectal pairs, 163 (68.5%) isolated GNB only
in the rectal sample, 31 pairs (13.0%) had no growth in either
samples, 7 pairs (2.9%) isolated GNB only in blood and in 37 pairs
(15.5%) GNB were isolated both in rectal and blood samples. The
median duration between birth of the neonate and positive
identification of GNB in their rectal samples was 6 days (IQR 4–9
days) and for GNB in their blood samples was 5 days (IQR = 3.5–7
days).
We isolated seven different species of GNB in blood samples
and 23 different species of GNB from rectal samples during the
study period (Table 1). The majority of blood samples showed no
growth (81.5%) (Table 1). The most common bacterial isolates from
blood samples were Klebsiella oxytoca (8.4%) and K. pneumoniae
(7.1%). In rectal samples, 12.9% showed no growth and the most
commonly isolated bacteria included K. pneumoniae (25.6%), E. coli
(15.5%), K. oxytoca (14.2%) and Enterobacter cloacae (7.4%) (Table 1).
Moreover, 14.3% of bacteria isolated from blood and 38.2% of
bacteria isolated from rectal samples were ESBL-producing
bacteria (Table 1).
Of the identified GNB isolates in blood samples, 34 (14.2%) were
ESBL-positive. In rectal samples there were 118 ESBL-producing
GNB isolates identified (38.2%). No other MDR isolates (apart from
the ESBL-positive isolates) were identified according to European
Committee on Antimicrobial Susceptibility Testing (EUCAST)
criteria [22].
3.2. Sensitivity, specificity, positive predictive value and negative
predictive value of rectal isolates
In all neonates for whom we had data, the overall sensitivity,
specificity, PPV and NPV of detecting GNB bacterial isolates in
rectal samples compared with those in blood samples was 84.1%,
16.0%, 18.5% and 81.6%, respectively. For ESBL-positive GNBisolates, the sensitivity was reduced, but the specificity, NPV
and PPV increased (Table 2).
The sensitivity for a positive GNB in a rectal sample remained
high for neonates with EOS, LOS and those receiving only first- or
second-line antibiotics (>80% for all categories). For all these
categories of neonates, the specificity and PPV remained low. The
NPV for each of these subgroups was between 76.0% and 100%. In
the group of neonates who only ever received second-line
antibiotics, we were unable to calculate the NPV owing to zero
results in the false negative and true negative parts of the two by
two table (Table 2).
There was a statistically significant difference in the proportion
of discordant blood and rectal isolates all groups, except in the
subgroup analysis for neonates who only received second-line
antibiotics (P = 0.06). This latter finding is likely due to the limited
number of samples that were eligible for this subgroup analysis
(Table 2).
3.3. Concordance by species and genus
Overall, the concordance in species between blood and rectal
isolates was 20.6% (95% CI 16.0–26.2%) (Table 3). This concordance
for all samples based on genus was slightly higher 22.3% (95% CI
17.4–28.0%). Concordance between rectal and blood samples was
slightly higher in neonates with EOS compared with those with
LOS (Table 3). When grouping neonates who only received first-
line antibiotics and only received second-line antibiotics, the
concordance was similar in these groups of neonates (20%)
(Table 3). The highest concordance occurred in rectal and blood
samples that had no growth (65%). The concordance was highest in
samples with no growth (n = 32; 65%) followed by samples that
isolated K. pneumoniae (n = 9; 18%) and samples that isolated K.
oxytoca (n = 6; 12%). There was one pair of rectal and blood samples
that displayed concordance for E. coli and E. cloacae.
Table 2
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of rectal and blood isolate pairs by bacterial groups in neonates with suspected
sepsis.
Patient group Bacteria
type
Positive blood
samples
Positive rectal
samples
Sensitivity Specificity PPV NPV McNemar’s
test
(P-value)
n (%) N n (%) N % 95% CI % 95% CI % 95% CI % 95% CI
Overall sepsis GNB 44 (18.5) 238 268
(86.7)
309 84.1 69.9–
93.4
16.0 11.1–21.9 18.5 13.4–
24.6
81.6 65.7–
92.3
<0.001
ESBL + GNB 34 (14.3) 238 118 (38.2) 309 70.6 52.5–
84.9
61.3 54.2–
68.0
23.3 15.5–
32.7
92.6 86.8–
96.4
<0.001
EOS GNB 6 (16.7) 36 29 (67.4) 43 83.3 35.9–
99.6
40.0 22.7–
59.4
21.7 7.5–43.7 92.3 64.0–
99.8
<0.001
LOS GNB 38 (18.8) 202 240 (90.2) 266 84.2 68.7–
94.0
11.6 7.1–17.5 18.1 12.7–
24.6
76.0 54.9–
90.6
<0.001
Only first-line antibiotics GNB 3 (10.3) 29 36 (92.3) 39 100 29.2–100 11.5 2.5–30.2 11.5 2.5–30.2 100 29.2–100 <0.001
Only second-line
antibiotics
GNB 4 (44.4) 9 14 (100) 14 100 39.8–100 0.0 0.0–52.2 44.4 13.7–
78.8
Undef. 0.06
CI, confidence interval; GNB, Gram-negative bacteria; ESBL, extended-spectrum β-lactamase; EOS, early-onset sepsis; LOS, late-onset sepsis.
Table 3
Concordance between Gram-negative bacteria isolates from blood and rectal sample pairs according to species and genus group.
Patient group N Species Genus
Concordant pairs Concordance (%) 95% CI Concordant pairs Concordance (%) 95% CI
All suspected sepsis 238 49 20.6 16.0–26.2 53 22.3 17.4–28.0
All EOS 36 14 38.8 24.8–55.1 14 38.8 24.8–55.1
All LOS 202 35 17.3 12.7–23.1 39 19.3 14.5–25.3
First-line antibiotic recipients 50 10 20.0 11.2–33.0 10 20.0 11.2–33.0
Second-line antibiotic recipients 130 28 21.5 15.3–29.4 32 24.6 18.0–32.7
Third-line antibiotic recipients 2 1 50.0`` 9.5–90.5 1 50.0 9.5–90.5
CI, confidence interval; EOS, early-onset sepsis; LOS, late-onset sepsis.
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The results from this study suggest that the concordance
between rectal GNB isolates and blood GNB isolates in neonates
with suspected sepsis is very low. As a consequence, the PPV for
GNB isolates from rectal swabs for predicting confirmed BSIs (and
the implicated bacterial pathogen) is low in neonates in this low-
resource setting of Port-au-Prince, Haiti. The low concordance and
PPV applies both to neonates with suspected EOS and LOS and is
not dependent on the MDR profile of the isolated bacteria.
Our findings are in line with those from a recent meta-analysis
where it was shown that only 7.9% of diagnosed BSIs were
concordant with gut or rectal colonisation results [17]. However,
they contrast with findings from the USA where Smith et al. found
that 98% of BSIs caused by GNB were preceded by gastrointestinal
colonisation of the same species from weekly surveillance rectal
swabs [14]. It is unlikely that surveillance and microbiological
diagnostics in low-resources settings such as Haiti would achieve
similar results as in the USA as the yield on blood cultures from
neonates are likely to be lower.
The management and diagnosis of neonatal sepsis is a challenge
for numerous reasons. Neonatal sepsis is very non-specific in its
clinical presentation and multiple conditions will mimic the signs
and symptoms of sepsis [10,23]. Furthermore, use of blood culture
for the diagnosis of confirmed BSIs has several limitations. These
include the low positivity rate in neonatal blood cultures [10] and
the time required to receive the final microbiological results (not
considering the additional delay from microbiological laboratories
not working on weekends in low-resource settings). A combination
of factors means that clinicians have little reliable information to
aid them in deciding to (de)-escalate antibiotic therapy in neonates
with suspected (ongoing) sepsis. Our study showed that the NPV of
rectal swab isolates was >75% in all patient groups included in thestudy and 92.6% for ESBL-positive GNB. This finding suggests that
in a context where simultaneous rectal swabs are being taken for
surveillance purposes (i.e. during a context of repeated outbreaks
of MDR-GNB), clinicians can use the results from rectal swabs (that
arrive sooner than blood culture results) together with other
clinical parameters to decide not to escalate antibiotic therapy in
those neonates that have an ongoing sepsis profile. Thus, enhanced
rectal swab surveillance can improve the antibiotic choice. It
should be noted that most neonates will become colonised with
GNB within 1 week after their birth, thus the true added value of
rectal swab surveillance for antibiotic stewardship might be
reduced after this period. A recent study in Spain showed that
neonatal colonisation with ESBL-producing Enterobacteriaceae
was associated with maternal vaginal colonisation with the same
organism [24]. Use of vaginal colonisation surveillance in the
identification and early treatment of neonatal sepsis could also be
further investigated in low- and middle-resource countries.
The main limitation of this study is that it is based on
opportunistic analysis of surveillance and clinical microbiolog-
ical analyses. The data collection was therefore not established
with the intention of conducting this study, thus the sample size
is small. Also, it should be noted that the data used for the study
were collected in a low-resource setting, which might have
contributed to suboptimal biological sample collection, trans-
port and reporting. Moreover, true concordance for bacterial
isolates can only be established through molecular typing (such
as whole-genome sequencing), thus our results only provide a
suggestion to explore this in more detail with more advanced
methods. Finally, the proportion of K. oxytoca isolates producing
ESBL was higher than expected in this context. It is possible that
this is due to the overproduction of K1 β-lactamase by these
isolates [25], however we were unable to confirm this with
additional laboratory testing.
6 A. Lenglet et al. / Journal of Global Antimicrobial Resistance 23 (2020) xxx–xxxIn conclusion, rectal screening swabs during outbreaks in NCUs
might contribute to improved de-escalation practices in antibiotic
treatment, particularly for ESBL-positive GNB. We recommend that
these findings are validated in a prospective manner in other
neonatal care settings with larger sample sizes. This will allow to
evaluate the more practical implications of such surveillance
(delay in results etc.) and would allow for accurate documentation
of the clinical impact of using rectal swab surveillance to inform
antibiotic treatment in neonates.
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